Roche announced that the company has obtained a worldwide co-exclusive license for the biomarker PI3K (phosphoinositide 3-kinase) from QIAGEN to develop real-time and endpoint PCR diagnostic assays.
Automating and Miniaturizing Gene Expression Assays via High-Throughput RT-qPCR Luciferase (firefly) reporter gene assays have been the industry standard in high-throughput screening (HTS) for more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results